Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 2
1949 4
1950 4
1951 9
1952 12
1953 8
1954 16
1955 10
1956 4
1957 10
1958 12
1959 7
1960 11
1961 10
1962 12
1963 12
1964 6
1965 12
1966 15
1967 23
1968 23
1969 18
1970 15
1971 17
1972 31
1973 28
1974 33
1975 17
1976 27
1977 37
1978 38
1979 44
1980 38
1981 45
1982 40
1983 47
1984 53
1985 52
1986 61
1987 61
1988 92
1989 94
1990 92
1991 108
1992 99
1993 109
1994 136
1995 135
1996 180
1997 163
1998 185
1999 163
2000 211
2001 220
2002 232
2003 242
2004 237
2005 264
2006 285
2007 302
2008 327
2009 355
2010 371
2011 381
2012 415
2013 436
2014 461
2015 456
2016 447
2017 412
2018 461
2019 471
2020 505
2021 563
2022 532
2023 521
2024 132

Text availability

Article attribute

Article type

Publication date

Search Results

10,689 results

Results by year

Filters applied: . Clear all
Page 1
Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.
Müller M, Huber F, Arnaud M, Kraemer AI, Altimiras ER, Michaux J, Taillandier-Coindard M, Chiffelle J, Murgues B, Gehret T, Auger A, Stevenson BJ, Coukos G, Harari A, Bassani-Sternberg M. Müller M, et al. Immunity. 2023 Nov 14;56(11):2650-2663.e6. doi: 10.1016/j.immuni.2023.09.002. Epub 2023 Oct 9. Immunity. 2023. PMID: 37816353 Free article.
Red Blood Cell Transfusion in the Intensive Care Unit.
Raasveld SJ, de Bruin S, Reuland MC, van den Oord C, Schenk J, Aubron C, Bakker J, Cecconi M, Feldheiser A, Meier J, Müller MCA, Scheeren TWL, McQuilten Z, Flint A, Hamid T, Piagnerelli M, Tomic Mahecic T, Benes J, Russell L, Aguirre-Bermeo H, Triantafyllopoulou K, Chantziara V, Gurjar M, Myatra SN, Pota V, Elhadi M, Gawda R, Mourisco M, Lance M, Neskovic V, Podbregar M, Llau JV, Quintana-Diaz M, Cronhjort M, Pfortmueller CA, Yapici N, Nielsen ND, Shah A, de Grooth HJ, Vlaar APJ; InPUT Study Group. Raasveld SJ, et al. Among authors: muller mca. JAMA. 2023 Nov 21;330(19):1852-1861. doi: 10.1001/jama.2023.20737. JAMA. 2023. PMID: 37824112
How to … YAG-​Kapsulotomie.
Jandewerth T, Müller M, Kohnen T. Jandewerth T, et al. Among authors: muller m. Ophthalmologie. 2022 Nov;119(11):1164-1166. doi: 10.1007/s00347-022-01752-x. Ophthalmologie. 2022. PMID: 36380238 German. No abstract available.
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
Kraemer AI, Chong C, Huber F, Pak H, Stevenson BJ, Müller M, Michaux J, Altimiras ER, Rusakiewicz S, Simó-Riudalbas L, Planet E, Wiznerowicz M, Dagher J, Trono D, Coukos G, Tissot S, Bassani-Sternberg M. Kraemer AI, et al. Among authors: muller m. Nat Cancer. 2023 May;4(5):608-628. doi: 10.1038/s43018-023-00548-5. Epub 2023 May 1. Nat Cancer. 2023. PMID: 37127787 Free PMC article.
[CME: Hypertriglyceridemia].
Müller M, Heim Classen M, Kamber N. Müller M, et al. Praxis (Bern 1994). 2023 Jun;112(7-8):367-372. doi: 10.1024/1661-8157/a004060. Praxis (Bern 1994). 2023. PMID: 37282527 German.
Heinz-Günter Floss (1934-2022).
Müller M, Kirschning A. Müller M, et al. Angew Chem Int Ed Engl. 2023 Aug 1;62(31):e202305459. doi: 10.1002/anie.202305459. Epub 2023 Jul 18. Angew Chem Int Ed Engl. 2023. PMID: 37464956
Molecular Highway Patrol for Ribosome Collisions.
Iyer KV, Müller M, Tittel LS, Winz ML. Iyer KV, et al. Among authors: muller m. Chembiochem. 2023 Oct 17;24(20):e202300264. doi: 10.1002/cbic.202300264. Epub 2023 Aug 10. Chembiochem. 2023. PMID: 37382189 Review.
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Among authors: muller m. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
Osteomodulin downregulation is associated with osteoarthritis development.
Zappia J, Tong Q, Van der Cruyssen R, Cornelis FMF, Lambert C, Pinto Coelho T, Grisart J, Kague E, Lories RJ, Muller M, Elewaut D, Hammond CL, Sanchez C, Henrotin Y. Zappia J, et al. Among authors: muller m. Bone Res. 2023 Sep 20;11(1):49. doi: 10.1038/s41413-023-00286-5. Bone Res. 2023. PMID: 37730805 Free PMC article.
10,689 results
You have reached the last available page of results. Please see the User Guide for more information.